This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Mednax Collaborates With Northern Indiana Neonatal Associates
by Zacks Equity Research
Mednax (MD) joins forces with Northern Indiana Neonatal Associates in Fort Wayne to enhance its neonatal services.
Here's Why Cigna (CI) is an Attractive Investment Option Now
by Zacks Equity Research
Cigna (CI) remains well poised for growth on the back of Express Scripts acquisition.
Ensign Group to Spin Off Home Health & Hospice Business
by Zacks Equity Research
Ensign Group (ENSG) to separate its home health and hospice business from the parent company.
Why Is Molina (MOH) Down 4.4% Since Last Earnings Report?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Buy Stocks for August 29th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
Magellan Healths Growth Measures Aid Investors' Confidence
by Zacks Equity Research
Magellan Health's (MGLN) initiatives to add new business and reduce cost of goods sold aid growth.
Humana Ties Up to Enhance Facilities for Members in Michigan
by Zacks Equity Research
Humana (HUM) teams up with McLaren Physician Partners to provide in-network access to its members in Michigan.
Is Molina Healthcare (MOH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Is Molina (MOH) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Ensign Group (ENSG) Up 33.2% in a Year: More Room for Rally?
by Zacks Equity Research
Ensign Group's (ENSG) revenue stream and strategic initiatives should bolster revenue growth. This will likely support its share price going forward.
The Zacks Analyst Blog Highlights: Molina, Universal Health, Allstate and YETI
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Molina, Universal Health, Allstate and YETI
Stimulus Hopes Keep Dollar's Head High: 4 Stocks to Add
by Sapna Bagaria
Dollar continues to retain the strongest position amongst other currencies, due to a better state of the U.S. economy.
Can Value Investors Consider Molina Healthcare (MOH) Stock?
by Zacks Equity Research
Molina Healthcare (MOH) stock may be a good choice for value-oriented investors right now from multiple angles.
MOH vs. JYNT: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
Molina Healthcare's Arm Joins Abarca for Better Medical Care
by Zacks Equity Research
Molina Healthcare's (MOH) subsidiary collaborates with Abarca to enable its members to easily avail Medication Therapy Management services.
Ensign Group Acquires Nursing Facility to Expand in Arizona
by Zacks Equity Research
Ensign Group (ENSG) purchases the real estate and operations of Surprise Health and Rehabilitation Center to boost presence in Arizona.
Why Should You Add Universal Health (UHS) to Your Portfolio?
by Zacks Equity Research
Banking on its solid second-quarter results and a growing bottom line, Universal Health (UHS) holds potential to garner benefits for investors.
Tenet Healthcare's Senior Secured Notes Get Rating Actions
by Zacks Equity Research
Tenet Healthcare's (THC) new senior secured first lien notes receive rating affirmations from Moody's. Outlook is stable.
Is Molina Healthcare (MOH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Top Ranked Growth Stocks to Buy for August 1st
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 1st.
Molina Healthcare (MOH) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) second-quarter earnings trump estimates on the back of lower expenses and the Meridian buyout.
Are Investors Undervaluing Molina (MOH) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina (MOH) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 21.48% and 2.93%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: United States Cellular, Kirkland Lake Gold, Hasbro and Molina Healthcare
by Zacks Equity Research
Zacks.com featured highlights include: United States Cellular, Kirkland Lake Gold, Hasbro and Molina Healthcare
Buy 6 Top Stocks Set to Beat on Earnings in Q2 Today
by Nalak Das
Second-quarter 2019 earnings expectations have improved this month. In spite of a prolonged trade conflict with China, we do not see a broad-based decline in guidance by U.S. corporates.